Injectable hydrogel encapsulating siMMP13 with anti-ROS and anti-apoptotic functions for osteoarthritis treatment.

Autor: Ji, Zhongyin^1,2,3 (AUTHOR), Ren, Xiaobin⁴ (AUTHOR), Jin, Jiayan^1,2 (AUTHOR), Ye, Xin^1,2 (AUTHOR), Yu, Hao⁴ (AUTHOR), Fang, Wenhan⁵ (AUTHOR), Li, Hui^1,2 (AUTHOR), Zhao, Yihao^1,2 (AUTHOR), Tao, Siyue^1,2 (AUTHOR), Kong, Xiangxi^1,2 (AUTHOR), Cheng, Jiao^1,2 (AUTHOR), Shan, Zhi^1,2 (AUTHOR), Chen, Jian^1,2 (AUTHOR), Yao, Qingqing⁴ (AUTHOR) qingqingyao@wmu.edu.cn, Zhao, Fengdong^1,2 (AUTHOR) zhaofengdong@zju.edu.cn, Liu, Junhui^1,2 (AUTHOR) ljhzju@zju.edu.cn

Publikováno v: Journal of Nanobiotechnology. 8/2/2024, Vol. 22 Issue 1, p1-20. 20p.

TLR-adjuvanted nanoparticle vaccines differentially influence the quality and longevity of responses to malaria antigen Pfs25.

Autor: Thompson EA; Department of Medicine Solna, Division of Immunology and Allergy, and.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Ols S; Department of Medicine Solna, Division of Immunology and Allergy, and.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden., Miura K; Laboratory of Malaria and Vector Research and., Rausch K; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA., Narum DL; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA., Spångberg M; Astrid Fagraeus Laboratory, Karolinska Institutet, Stockholm, Sweden., Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wille-Reece U; PATH's Malaria Vaccine Initiative, Washington, DC, USA., Weiner A; Bill and Melinda Gates Foundation, Seattle, Washington, USA., Howard RF; Infectious Disease Research Institute, Seattle, Washington, USA., Long CA; Laboratory of Malaria and Vector Research and., Duffy PE; Laboratory of Malaria Immunology and Vaccinology, National Institute of Allergy and Infectious Diseases, NIH, Rockville, Maryland, USA., Johnston L; Selecta Biosciences Inc., Watertown, Massachusetts, USA., O'Neil CP; Selecta Biosciences Inc., Watertown, Massachusetts, USA., Loré K; Department of Medicine Solna, Division of Immunology and Allergy, and.; Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.

Publikováno v: JCI insight [JCI Insight] 2018 May 17; Vol. 3 (10). Date of Electronic Publication: 2018 May 17 (Print Publication: 2018).

Nano-fluorescence imaging: advancing lymphatic disease diagnosis and monitoring.

Autor: Han, Chae Yeon, Choi, Sang-Hun, Chi, Soo-Hyang, Hong, Ji Hyun, Cho, Young-Eun, Kim, Jihoon

Publikováno v: Nano Convergence; 12/11/2024, Vol. 11 Issue 1, p1-23, 23p

Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release.

Autor: Ilyinskii PO; Selecta Biosciences, Watertown, MA 02472, USA. Electronic address: PIlyinskii@selectabio.com., Roy CJ; Selecta Biosciences, Watertown, MA 02472, USA., O'Neil CP; Selecta Biosciences, Watertown, MA 02472, USA., Browning EA; Selecta Biosciences, Watertown, MA 02472, USA., Pittet LA; Selecta Biosciences, Watertown, MA 02472, USA., Altreuter DH; Selecta Biosciences, Watertown, MA 02472, USA., Alexis F; Laboratory of Nanomedicine and Biomaterials, Brigham and Women's Hospital, Boston, MA 02115, USA., Tonti E; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA., Shi J; Laboratory of Nanomedicine and Biomaterials, Brigham and Women's Hospital, Boston, MA 02115, USA., Basto PA; David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA., Iannacone M; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA., Radovic-Moreno AF; David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA., Langer RS; David H. Koch Institute for Integrative Cancer Research, Cambridge, MA 02139, USA; Harvard-MIT Division of Health Sciences and Technology, Cambridge, MA 02139, USA., Farokhzad OC; Laboratory of Nanomedicine and Biomaterials, Brigham and Women's Hospital, Boston, MA 02115, USA., von Andrian UH; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA., Johnston LP; Selecta Biosciences, Watertown, MA 02472, USA., Kishimoto TK; Selecta Biosciences, Watertown, MA 02472, USA.

Publikováno v: Vaccine [Vaccine] 2014 May 19; Vol. 32 (24), pp. 2882-95. Date of Electronic Publication: 2014 Mar 01.

Injectable photocrosslinking spherical hydrogel-encapsulated targeting peptide-modified engineered exosomes for osteoarthritis therapy.

Autor: Wan, Junlai^1,2 (AUTHOR), He, Zhiyi¹ (AUTHOR), Peng, Renpeng¹ (AUTHOR), Wu, Xiaopei³ (AUTHOR), Zhu, Ziqing¹ (AUTHOR), Cui, Jiarui⁴ (AUTHOR), Hao, Xiaoxia⁵ (AUTHOR), Chen, Anmin¹ (AUTHOR) anminchen@hust.edu.cn, Zhang, Jiaming¹ (AUTHOR) jiaming_zhangtjmc@icloud.com, Cheng, Peng¹ (AUTHOR) chengpeng2015@tjh.tjmu.edu.cn

Publikováno v: Journal of Nanobiotechnology. 8/21/2023, Vol. 21 Issue 1, p1-21. 21p.